Monday Movers In Biotech: Cempra Inc (CEMP) And IntelliPharmaCeutics Intl Inc (USA) (IPCI)
It’s going to be a good start to the week for a few companies in the biotech space, after a raft of positive news hit the wires on Friday.
Posts Tagged ‘NASDAQ:CEMP’
Nvidia (NVDA) Can’t Shake Citron, Cempra (CEMP) Slammed by FDA Rejection, Plus 3 Other Major Movers
The second-to-last trading day of 2016 is showing little volatility in the broader market, with the S&P, Dow, and Nasdaq all being close to flat (the Nasdaq is faring the worst...
How Cempra Inc (CEMP) Stacks Up Against Its Peers?
Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dollars of accredited investors' money...
Why Chipotle, Baidu, Cempra, and More Are in the Spotlight
In this article, we'll find out why Chipotle Mexican Grill, Inc.
Biotech Movers on Thursday: Cempra Inc (CEMP) And Opexa Therapeutics Inc (OPXA)
Another big day in the biotech sector? You bet.
Why Brocade, Cempra, Apple, and Two Other Stocks Are in Spotlight Today
WTI futures are down 3% today after the EIA reported that oil inventories rose by 14.4 million barrels last week.
Here’s Our Take On Cempra Inc (CEMP)’s Delay
Cempra Inc (NASDAQ:CEMP) just announced that it may not meet its PDUFA for solithromycin, and the company has taken a big hit on the news.
Cempra Inc. (CEMP) Stock: Levin Capital Cuts 300,000 Shares
Levin Capital Strategies, managed by John A. Levin, has revealed through a 13G filing that it has reduced its stake in Cempra Inc. (NASDAQ:CEMP).
Why Investors Are Buzzing About Threshold Pharmaceuticals, Enbridge, Facebook and More
With the third quarter officially wrapping up at the end of Friday's close, unexpected volatility in either direction could potentially appear at any time.
Cempra Inc (CEMP) Has A Busy Fourth Quarter Coming Up
Those familiar with the biotech space will no doubt already be aware of the development solithromycin – Cempra Inc (NASDAQ:CEMP)’s pneumonia drug.
Biotech Movers: Insys Therapeutics Inc (INSY) and Cempra Inc (CEMP)
The long weekend is over in the US, and the markets are back in full swing on Tuesday.
Cempra, Inc. (CEMP): Aisling Capital Slashes Stake as Stock Sinks
Dennis Purcell's Aisling Capital has sold off nearly 1.00 million shares of Cempra Inc (NASDAQ:CEMP) since the end of December according to a new 13D filing.
Here is What Hedge Funds Think About Cempra Inc (CEMP)
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
What Has These Insiders Excited About Their Companies’ Stock?
Investors have been monitoring insider trading activity for years, as corporate insiders surely have more in-depth knowledge about their companies’ operations and industries...
What’s The Deal With These Sinking Stocks?
It's Tuesday and shareholders of Depomed Inc (NASDAQ:DEPO), Allegheny Technologies Incorporated (NYSE:ATI), Cempra Inc (NASDAQ:CEMP), and Hexcel Corporation (NYSE:HXL) could...
Why Are These Stocks Surging?
At a time when the S&P is roughly flat, shares of Weight Watchers International, Inc.
Why Are These Stocks Trending In The Wrong Direction Today?
Both the NASDAQ and S&P 500 are slightly in the green this morning as positive momentum continues to buffet the market.
More Than 60% Returns For These Two Hedgies’ Favorite Health Care Picks
The health care sector has appreciated by nearly 30% over the past year. We decided to take a look at three companies that two health care-focused funds, namely James A.
Aisling Capital Reduces Stake in Cempra Inc (CEMP)
Dennis Purcell's Aisling Capital recently filed an amended 13D with the SEC disclosing a reduced stake in Cempra Inc (NASDAQ:CEMP).
Esperion Therapeutics Inc (ESPR), Cempra Inc (CEMP), Zeltiq Aesthetics Inc (ZLTQ): Aisling Capital’s Winning Plays in Small-Cap Healthcare Stocks
On Tuesday, Esperion Therapeutics Inc (NASDAQ:ESPR)'s stock closed the trading section as one of the market leaders, ending the day up by 29%.
OncoGenex Pharmaceuticals Inc (OGXI): Are Hedge Funds Right About This Stock?
To the average investor, there are many gauges shareholders can use to monitor stocks. Two of the most underrated are hedge fund and insider trading movement.
Hedge Funds Are Dumping Cytori Therapeutics Inc. (USA) (CYTX)
In the eyes of most stock holders, hedge funds are perceived as underperforming, old financial tools of the past.
Hedge Funds Are Betting On Cytori Therapeutics Inc. (USA) (CYTX)
Is Cytori Therapeutics Inc. (USA) (NASDAQ:CYTX) a marvelous investment now? Investors who are in the know are becoming more confident.
Enzon Pharmaceuticals, Inc. (ENZN): Are Hedge Funds Right About This Stock?
Is Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) a buy, sell, or hold? The best stock pickers are taking a bearish view.
